Mirum Pharmaceuticals (MIRM) PT Lowered to $137 at Citizens
Tweet
Share
E-mailGet Alerts MIRM Hot Sheet
Price: $99.83 +1.52%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 32
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 32
Join SI Premium – FREE
Citizens analyst Jonathan Wolleben lowered the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $137.00 (from $146.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- ONEOK Inc (OKE) PT Raised to $104 at Truist Securities
- Palo Alto Networks (PANW) PT Raised to $420 at DA Davidson on Strong Q4 Upside
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
